EdgeLab S.p.A. Logo

EdgeLab S.p.A.

Specializing in underwater robotics, AUVs, and sensor systems for marine research and heritage.

ELB | Euronext Growth

Overview

Corporate Details

ISIN(s):
IT0005627762
LEI:
815600DEC35C84FE7546
Country:
Italy
Address:
Via della Ferriera 1, 57037 Portoferraio
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

EdgeLab S.p.A. is a high-technology company specializing in the development of marine and underwater solutions and technologies. Established in 2010 as a spinoff from scientific research projects, the company's core activities include underwater robotics, Autonomous Underwater Vehicles (AUVs), marine technologies, and advanced sensor systems. EdgeLab also provides research and consultancy services, with a focus on projects related to environmental sustainability and the preservation of underwater marine heritage. The company transitioned to a joint-stock company and was listed on Euronext Growth Milan in December 2024.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 18:42
Related Party Transaction
EDGELAB E KSSL SIGLANO UN ACCORDO STRATEGICO PER RAFFORZARE LA COOPERAZIONE IN…
Italian 267.9 KB
2025-10-13 20:01
Report Publication Announcement
EDGELAB PARTECIPA ALLA SESTA EDIZIONE DELLA CONFERENCE EQUITY “NEXT GEMS”
Italian 271.6 KB
2025-09-30 20:53
Earnings Release
EDGELAB: IL CONSIGLIO DI AMMINISTRAZIONE HA APPROVATO LA RELAZIONE SEMESTRALE …
Italian 522.5 KB
2025-08-07 12:36
Regulatory Filings
ACCORDO COMMERCIALE GOLDEN POWER BFL
Italian 269.2 KB
2025-04-30 16:00
AGM Information
L’ASSEMBLEA DEGLI AZIONISTI DI EDGELAB APPROVA IL BILANCIO 2024
Italian 282.4 KB
2025-04-10 12:57
Pre-Annual General Meeting Information
PUBBLICAZIONE DELL'AVVISO DI CONVOCAZIONE DELL'ASSEMBLEA ORDINARIA
Italian 302.6 KB
2025-02-21 15:08
Environmental & Social Information
Training_Soprintendenza del Mare-Regione Sicilia
Italian 256.7 KB
2025-01-28 17:44
Board/Management Information
IL CONSIGLIO DI AMMINISTRAZIONE DI EDGELAB S.P.A. HA APPROVATO I CRITERI VALUT…
Italian 269.4 KB
2025-01-15 18:48
Report Publication Announcement
CALENDARIO EVENTI SOCIETARI 2025
Italian 267.8 KB
2024-12-30 19:39
Regulatory Filings
EDGELAB DEBUTTA CON SUCCESSO SU EGM
Italian 275.5 KB

Automate Your Workflow. Get a real-time feed of all EdgeLab S.p.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EdgeLab S.p.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EdgeLab S.p.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
Rain Enhancement Technologies Holdco, Inc. Logo
Develops ionization tech to generate rain and mitigate fog for water-scarce regions.
United States of America
RAIN
Rallybio Corp Logo
Develops therapies for severe and rare diseases in hematology and complement dysregulation.
United States of America
RLYB
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
RECURSION PHARMACEUTICALS, INC. Logo
AI-driven biotech accelerating drug discovery for rare diseases and oncology.
United States of America
RXRX
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
RenovoRx, Inc. Logo
Develops a device platform for delivering targeted therapies directly to solid tumors.
United States of America
RNXT
Repare Therapeutics Inc. Logo
Develops precision oncology drugs using a CRISPR platform for cancers with genomic instabilities.
United States of America
RPTX
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978

Talk to a Data Expert

Have a question? We'll get back to you promptly.